Evidence map›Paper›PMID 35032046›Full record

ArticlePrenatal diagnosis2022

The prevalence of prenatal sonographic findings in postnatal diagnostic exome sequencing performed for neurocognitive phenotypes: A cohort study.

Rivka Sukenik-Halevy, Sharon Perlman, Noa Ruhrman-Shahar, Offra Engel, Naama Orenstein, Claudia Gonzaga-Jauregui, Alan R Shuldiner, Regeneron Genetics Center, Nurit Magal, Ofir Hagari and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Prenatal diagnosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Obtaining a Diagnostic Yield via Scan findings prior to the introduction of SEquencing retrospectivelY (ODYSSEY): a cohort study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2026
    Article
  2. Article
  3. De NovoInternational journal of molecular sciences · 2025
    Review
  4. A Rare De Novo Mutation in theInternational journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Rivka Sukenik-HalevyRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.ORCID 0000-0003-4418-7551
Sharon PerlmanSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Noa Ruhrman-ShaharRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Offra EngelDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
Naama OrensteinPediatric Genetics Clinic, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Claudia Gonzaga-JaureguiRegeneron Genetics Center, Tarrytown, New York, USA.
Alan R ShuldinerRegeneron Genetics Center, Tarrytown, New York, USA.
Regeneron Genetics CenterRegeneron Genetics Center, Tarrytown, New York, USA.
Nurit MagalRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Ofir HagariRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Noy AzulayRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Gabriel Arie LidzbarskyRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Lily BazakRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Lina Basel-SalmonRaphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.
Rafael Advanced Defense Systems (Israel) · ILRegeneron (United States) · USMeir Medical Center · ILSchneider Children's Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePrenatal exome sequencing (ES) is currently indicated for fetal malformations. Some neurocognitive genetic disorders may not have a prenatal phenotype. We assessed the prevalence of prenatally detectable phenotypes among patients with neurocognitive syndromes diagnosed postnatally by ES.

methodsThe medical files of a cohort of 138 patients diagnosed postnatally with a neurocognitive disorder using ES were reviewed for prenatal sonographic data. The Online Mendelian Inheritance in Man (OMIM) database was searched for prenatally detectable phenotypes for all genes identified.

resultsPrenatal imaging data were available for 122 cases. Of these, 29 (23.75%) had fetal structural abnormalities and another 29 had other ultrasound abnormalities (fetal growth restriction, polyhydramnios, elevated nuchal translucency). In 30 patients, structural aberrations that were not diagnosed prenatally were detected at birth; in 21 (17.2%), the abnormalities could theoretically be detected prenatally by third-trimester/targeted scans. According to OMIM, 55.9% of the diagnosed genes were not associated with structural anomalies.

conclusionsMost patients (52.5%) with postnatally diagnosed neurocognitive disorders did not have prenatal sonographic findings indicating prenatal ES should be considered. The prevalence of specific prenatal phenotypes such as fetal growth restriction and polyhydramnios in our cohort suggests that additional prenatal findings should be assessed as possible indications for prenatal ES.

Indexed as

PolyhydramniosPrenatal DiagnosisCohort StudiesExomeFemaleFetal Growth RetardationHumansPhenotypePregnancyPrevalenceUltrasonography, Prenatal

Identifiers

PMID35032046
PMCPMC9303252
OpenAlexW4206203672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.